BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24548744)

  • 1. Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review.
    Zhang X; Zhang L; Tian C; Yang L; Wang Z
    BJOG; 2014 May; 121(6):664-74. PubMed ID: 24548744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
    Zhang B; Beeghly-Fadiel A; Long J; Zheng W
    Lancet Oncol; 2011 May; 12(5):477-88. PubMed ID: 21514219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA-DQB1 gene polymorphisms associated with cervical cancer risk: A meta-analysis.
    Zhang X; Lv Z; Yu H; Wang F; Zhu J
    Biomed Pharmacother; 2015 Jul; 73():58-64. PubMed ID: 26211583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study of susceptibility loci for cervical cancer.
    Chen D; Juko-Pecirep I; Hammer J; Ivansson E; Enroth S; Gustavsson I; Feuk L; Magnusson PK; McKay JD; Wilander E; Gyllensten U
    J Natl Cancer Inst; 2013 May; 105(9):624-33. PubMed ID: 23482656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women.
    Gokhale P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Salvi V; Mania-Pramanik J
    Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S36-43. PubMed ID: 25673541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the XRCC3 Thr241Met polymorphism and cervical cancer risk: a meta-analysis.
    Qin LY; Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6703-7. PubMed ID: 24377592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HLA-DQB1 allele polymorphisms in Uyghur women with cervical cancer.
    Han L; Husaiyin S; Wang L; Wusainahong KD; Fu X; Niyazi M
    Genet Mol Res; 2015 Dec; 14(4):17252-61. PubMed ID: 26681219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-DQA1 and -DQB1 alleles with type I diabetes in Arabs: a meta-analyses.
    Hamzeh AR; Nair P; Al-Khaja N; Al Ali MT
    Tissue Antigens; 2015 Jul; 86(1):21-7. PubMed ID: 26095634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CTLA4 gene polymorphism (rs5742909) with cervical cancer: a meta-analysis.
    Xu HB; Yang H; Liu T; Chen H
    Tumour Biol; 2014 Feb; 35(2):1605-8. PubMed ID: 24122201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1β and interleukin 1 receptor antagonist gene polymorphisms and cervical cancer: a meta-analysis.
    Wu S; Hu G; Chen J; Xie G
    Int J Gynecol Cancer; 2014 Jul; 24(6):984-90. PubMed ID: 24905619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression profiling-based copy number variations and colorectal cancer risk in Chinese.
    Wang K; Yu X; Jiang H; Huang J; Wang H; Jiang H; Wei S; Liu L
    Mol Carcinog; 2019 Jul; 58(7):1324-1333. PubMed ID: 31001878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic investigation of contribution of genetic variation in the HLA-DP region to cervical cancer susceptibility.
    Chen D; Gyllensten U
    Carcinogenesis; 2014 Aug; 35(8):1765-9. PubMed ID: 24743517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2.
    Ivansson EL; Magnusson JJ; Magnusson PK; Erlich HA; Gyllensten UB
    Genes Immun; 2008 Oct; 9(7):613-23. PubMed ID: 18650831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Polymorphic Variants Conferring Genetic Risk to Cervical Cancer in Indian Women Supports CYP1A1 as an Important Associated Locus.
    Sengupta D; Guha U; Mitra S; Ghosh S; Bhattacharjee S; Sengupta M
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2071-2081. PubMed ID: 30139066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between the IL-6 rs1800795 Polymorphism and the Risk of Cervical Cancer: A Meta-Analysis of 1210 Cases and 1525 Controls.
    Liu H; Lyu D; Zhang Y; Sheng L; Tang N
    Technol Cancer Res Treat; 2017 Oct; 16(5):662-667. PubMed ID: 27777338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis.
    Li ZK; Nie JJ; Li J; Zhuang H
    Vaccine; 2013 Sep; 31(40):4355-61. PubMed ID: 23887040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA and post-schistosomal hepatic disorder: a systematic review and meta-analysis.
    Huy NT; Hamada M; Kikuchi M; Lan NT; Yasunami M; Zamora J; Hirayama K
    Parasitol Int; 2011 Dec; 60(4):347-56. PubMed ID: 21664486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host genetic variants in sepsis risk: a field synopsis and meta-analysis.
    Lu H; Wen D; Wang X; Gan L; Du J; Sun J; Zeng L; Jiang J; Zhang A
    Crit Care; 2019 Jan; 23(1):26. PubMed ID: 30683156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II susceptibility to cervical cancer among Tunisian women.
    Ben Othmane Y; Ghazouani E; Mezlini A; Lagha A; Raïs M; Kochkar R; Zidi S; Afrit M; Mota-Vieira L; Yacoubi Loueslati B
    Bull Cancer; 2012 Sep; 99(9):81-6. PubMed ID: 22863772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the association between CTLA-4 +49 A/G, -318 C/T, and IL-1 polymorphisms and susceptibility to cervical cancer.
    Lee YH; Song GG
    Neoplasma; 2014; 61(4):481-90. PubMed ID: 24712845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.